Chemotherapy Stocks List



Recent Signals

Date Stock Signal Type
2021-04-09 ALKS MACD Bullish Signal Line Cross Bullish
2021-04-09 ALKS Bollinger Band Squeeze Range Contraction
2021-04-09 ALKS 200 DMA Support Bullish
2021-04-09 ATNX Narrow Range Bar Range Contraction
2021-04-09 BNTC Spinning Top Other
2021-04-09 BNTC 200 DMA Support Bullish
2021-04-09 BYSI 180 Bearish Setup Bearish Swing Setup
2021-04-09 CBLI Hammer Candlestick Bullish
2021-04-09 CBLI NR7 Range Contraction
2021-04-09 CBLI Fell Below 20 DMA Bearish
2021-04-09 CCM NR7 Range Contraction
2021-04-09 CCM Narrow Range Bar Range Contraction
2021-04-09 CHRS New 52 Week Closing Low Bearish
2021-04-09 CHRS New 52 Week Low Weakness
2021-04-09 CLSN Narrow Range Bar Range Contraction
2021-04-09 CLSN NR7-2 Range Contraction
2021-04-09 CLSN NR7 Range Contraction
2021-04-09 CRDF Narrow Range Bar Range Contraction
2021-04-09 CRDF Bollinger Band Squeeze Range Contraction
2021-04-09 CRDF Stochastic Reached Oversold Weakness
2021-04-09 DBTX New 52 Week Closing Low Bearish
2021-04-09 DFFN Narrow Range Bar Range Contraction
2021-04-09 DFFN New Downtrend Bearish
2021-04-09 DFFN Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-09 DFFN 180 Bearish Setup Bearish Swing Setup
2021-04-09 HRTX Fell Below 200 DMA Bearish
2021-04-09 ICUI Bollinger Band Squeeze Range Contraction
2021-04-09 ICUI NR7 Range Contraction
2021-04-09 INFU 20 DMA Support Bullish
2021-04-09 KPTI NR7 Range Contraction
2021-04-09 KPTI NR7-2 Range Contraction
2021-04-09 KZIA Slingshot Bullish Bullish Swing Setup
2021-04-09 KZIA Upper Bollinger Band Walk Strength
2021-04-09 MACK Narrow Range Bar Range Contraction
2021-04-09 MBRX Narrow Range Bar Range Contraction
2021-04-09 ORIC 180 Bearish Setup Bearish Swing Setup
2021-04-09 SGEN 20 DMA Resistance Bearish
2021-04-09 SPPI 180 Bearish Setup Bearish Swing Setup
2021-04-09 URGN Fell Below 20 DMA Bearish
2021-04-09 URGN Bollinger Band Squeeze Range Contraction
2021-04-09 VERU NR7 Range Contraction
2021-04-09 VERU Lizard Bullish Bullish Day Trade Setup
2021-04-09 VERU Hammer Candlestick Bullish
2021-04-09 VERU Narrow Range Bar Range Contraction
2021-04-09 VERU NR7-2 Range Contraction
2021-04-09 VNDA Fell Below 20 DMA Bearish
2021-04-09 ZEAL New Uptrend Bullish
2021-04-09 ZEAL Narrow Range Bar Range Contraction

Recent News for Chemotherapy Stocks

Date Stock Title
Apr 9 KPTI Revisiting Karyopharm Therapeutics
Apr 9 SGEN FDA accepts Genmab, Seagen's tisotumab vedotin BLA application for review
Apr 9 SGEN Genmab and Seagen Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
Apr 9 SGEN Seagen and Genmab Announce U.S. FDA Filing Acceptance for Priority Review of Tisotumab Vedotin Biologics License Application for Patients with Recurrent or Metastatic Cervical Cancer
Apr 9 CBLI SHAREHOLDER ALERT: WeissLaw LLP Reminds MDCA, PTVCA, CBLI, and WIFI Shareholders About Its Ongoing Investigations
Apr 9 ATNX ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Athenex, Inc. Investors With Losses to Secure Counsel Before Important Deadline - ATNX
Apr 9 MRSN Mersana Therapeutics Starts UpRi Dosing In Heavily Pretreated Cohort Of Ovarian Cancer Patients
Apr 9 MRSN Mersana Therapeutics starts dosing in upifitamab rilsodotin ovarian cancer study
Apr 9 MRSN Mersana Therapeutics to Host Conference Call and Webcast to Discuss the Selection of the NaPi2b Biomarker Cutoff and Commercial Diagnostic Development Path
Apr 9 MRSN Mersana Therapeutics Announces Initiation of UPLIFT Single-Arm Registration Strategy for UpRi in Platinum-Resistant Ovarian Cancer
Apr 9 SGEN Seagen to Highlight Data from Novel Targeted Therapies at AACR
Apr 8 ATNX The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ATNX, XL and VRM
Apr 8 ATNX HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athenex (ATNX) Investors with Losses to Contact Its Attorneys, Securities Class Action Filed
Apr 8 ATNX CLASS ACTION UPDATE for BLUE, OTRK and ATNX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Apr 8 ALKS Alkermes (ALKS) Inks Deal With Merck for Ovarian Cancer Study
Apr 8 CRDF Cardiff Oncology to Host Key Opinion Leader Webinar on Onvansertib for the Treatment of KRAS-Mutated Metastatic Colorectal Cancer
Apr 8 DBTX Decibel Therapeutics to Present at the 20th Annual Needham Virtual Healthcare Conference
Apr 8 ATNX SHAREHOLDER ALERT: UAVS IQDNX ATNX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
Apr 7 ATNX Lawsuits Filed Against Ebix, Atnx and Plug - Jakubowitz Law Pursues Shareholders Claims
Apr 7 ATNX Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Velodyne Lidar, Renewable Energy Group, Athenex, and Ontrak and Encourages Investors to Contact the Firm

Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen. Chemotherapy may be given with a curative intent (which almost always involves combinations of drugs), or it may aim to prolong life or to reduce symptoms (palliative chemotherapy). Chemotherapy is one of the major categories of the medical discipline specifically devoted to pharmacotherapy for cancer, which is called medical oncology.
The term chemotherapy has come to connote non-specific usage of intracellular poisons to inhibit mitosis, cell division. The connotation excludes more selective agents that block extracellular signals (signal transduction). The development of therapies with specific molecular or genetic targets, which inhibit growth-promoting signals from classic endocrine hormones (primarily estrogens for breast cancer and androgens for prostate cancer) are now called hormonal therapies. By contrast, other inhibitions of growth-signals like those associated with receptor tyrosine kinases are referred to as targeted therapy.
Importantly, the use of drugs (whether chemotherapy, hormonal therapy or targeted therapy) constitutes systemic therapy for cancer in that they are introduced into the blood stream and are therefore in principle able to address cancer at any anatomic location in the body. Systemic therapy is often used in conjunction with other modalities that constitute local therapy (i.e. treatments whose efficacy is confined to the anatomic area where they are applied) for cancer such as radiation therapy, surgery or hyperthermia therapy.
Traditional chemotherapeutic agents are cytotoxic by means of interfering with cell division (mitosis) but cancer cells vary widely in their susceptibility to these agents. To a large extent, chemotherapy can be thought of as a way to damage or stress cells, which may then lead to cell death if apoptosis is initiated. Many of the side effects of chemotherapy can be traced to damage to normal cells that divide rapidly and are thus sensitive to anti-mitotic drugs: cells in the bone marrow, digestive tract and hair follicles. This results in the most common side-effects of chemotherapy: myelosuppression (decreased production of blood cells, hence also immunosuppression), mucositis (inflammation of the lining of the digestive tract), and alopecia (hair loss). Because of the effect on immune cells (especially lymphocytes), chemotherapy drugs often find use in a host of diseases that result from harmful overactivity of the immune system against self (so-called autoimmunity). These include rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, vasculitis and many others.

More about Chemotherapy
Browse All Tags